Pericardial abscess: A rare complication of disseminated melioidosis in a patient with relapsed multiple myeloma

Pericardial abscess: A rare complication of disseminated melioidosis in a patient with relapsed multiple myeloma

Saved in:

Bibliographic Details
Main Authors:	Chee Yik Chang, Kai Xin Ang
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2025-03-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822025000100912&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Eikenella corrodens: An Extremely Rare Cause of Brain Abscess
by: Siew Ping Lau, et al.
Published: (2025-04-01)

Pericardial Abscess in an Immunocompromised Patient
by: Marion Larue, et al.
Published: (2024-01-01)

Abscesses due to Melioidosis: A case-based review
by: Nitin Gupta, et al.
Published: (2025-01-01)

A Rare Case of Extramedullary Relapse of Multiple Myeloma Causing Bowel Obstruction
by: Prarthna V. Bhardwaj, et al.
Published: (2019-01-01)

A Rare Presentation of Whitmore’s Disease (Melioidosis) with Multisystem Abscess in a Diabetic Patient with Intractable Hiccups
by: Vuppala Rachana, et al.
Published: (2025-04-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

T cell redirecting therapy for relapsed multiple myeloma
by: Melinda S. Y. Tan, et al.
Published: (2025-08-01)

Detection of early relapse in multiple myeloma patients
by: Tereza Růžičková, et al.
Published: (2025-01-01)

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
by: Diana V. Maslov, et al.
Published: (2021-01-01)

Listeria monocytogenes brain abscess in a patient with multiple myeloma
by: Adil A Al-Khatti, et al.
Published: (2010-07-01)

Hepatic/splenic abscess and/or skin and soft tissue infection as predictors of melioidosis in children
by: Supatjaree Chanvitan, et al.
Published: (2019-02-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Melioidosis with Septic Shock and Disseminated Infection in a Neutropenic Patient Receiving Chemotherapy
by: Sitthi Sukauichai, et al.
Published: (2020-01-01)

Hydropneumopericardium Due to Esophageal-Pericardial Fistula: A Rare Complication of Esophageal Stenting
by: Svenja Schneider, et al.
Published: (2025-06-01)

Coronary Stent Infection Complicated by Persistent Methicillin-Sensitive Staphylococcus aureus Bacteremia Myocardial Abscess and Pericardial Effusion
by: Nicole M. Robertson, et al.
Published: (2023-06-01)

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group
by: Jiri Minarik, et al.
Published: (2025-04-01)

Advances and perspective of the immunotherapy for relapsed/refractory multiple myeloma (interview)
by: S. V. Semochkin
Published: (2022-01-01)

Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study
by: V. G. Potapenko, et al.
Published: (2022-07-01)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
by: Jessica S. Little, et al.
Published: (2025-08-01)

A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma
by: Yutaka Tsutsumi, et al.
Published: (2022-01-01)

Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab
by: Deena Mudawi, et al.
Published: (2025-05-01)

A rare multiple myeloma complication as a spinal cord metastasis: A case report
by: Marah Mansour, et al.
Published: (2023-03-01)

Successful usage of external beam radiation to myeloma cutaneous lesions in patient with refractory, relapsed multiple myeloma
by: Chira Ranjan Khadanga, et al.
Published: (2019-01-01)

Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma
by: Shah B, et al.
Published: (2025-04-01)

Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma
by: A P Dubey, et al.
Published: (2020-01-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

The Gaining Momentum of BCMA-Directed Therapies for Relapsed/Refractory Multiple Myeloma
by: Adrian Schmidt
Published: (2023-10-01)

MAMDC2‐AS1 Induces Cuproptosis in Relapsed and Refractory Multiple Myeloma
by: Yifei Chen, et al.
Published: (2025-05-01)

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
by: Andrew J. Yee, et al.
Published: (2025-03-01)

Late Onset Ipilimumab-Induced Pericarditis and Pericardial Effusion: A Rare but Life Threatening Complication
by: Seongseok Yun, et al.
Published: (2015-01-01)

Myeloma multiplex with pulmonary dissemination
by: Terzić Brankica, et al.
Published: (2014-01-01)

New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review
by: OM Votyakova
Published: (2017-10-01)

EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma
by: Xiang Zhou, et al.
Published: (2024-10-01)

A Peculiar Case of Disseminated Melioidosis with Atypical Features Likely Linked to Bong/Water Pipe Use
by: Kisen Jang, et al.
Published: (2024-12-01)

Risk Factors and Predictive Model for Disseminated Intravascular Coagulation in Patients with Multiple Myeloma
by: Rong Bao MM, et al.
Published: (2025-02-01)

Pharmacoeconomic evaluation of carfilzomib versus ixazomib for the treatment of relapsed and refractory multiple myeloma
by: Lin Wang, et al.
Published: (2025-12-01)

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma [Letter]
by: Gupta-Werner N, et al.
Published: (2025-07-01)

Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma
by: Sijia Yan, et al.
Published: (2025-03-01)